GRFS
Grifols, S.A.
10.36
USD
This page is just a preview of the data found in TrendSpider’s full version
Grifols, S.A. stock is up 15.11% since 30 days ago. The next earnings date is Dec 22, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 7 December’s closed higher than November. In the last 4 Unusual Options Trades, there were 3 CALLs, 1 PUT. 0% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 17 Nov 20:04 | 17 Nov, 2023 | 5.00 | 364 | ||
| 20 Nov 14:55 | 17 May, 2024 | 7.50 | 20 | ||
| 22 Nov 15:09 | 17 May, 2024 | 7.50 | 470 | ||
| 06 Dec 14:45 | 17 May, 2024 | 12.50 | 0 |
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Company offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins.
